Most common drug-related adverse experiences in greater than 10% of patients
| Adverse experience . | Total†, n (%) . | All patients by grade*†, n (%) . | |||
|---|---|---|---|---|---|
| Group 1 . | Group 2 . | Group 3 . | Group 4 . | ||
| Fatigue | 27 (73) | 16 (43) | 10 (27) | 0 | 1 (3) |
| Thrombocytopenia | 20 (54) | 10 (27) | 3 (8) | 4 (11) | 3 (8) |
| Diarrhea | 18 (49) | 14 (38) | 4 (11) | 0 | 0 |
| Nausea | 18 (49) | 15 (41) | 3 (8) | 0 | 0 |
| Dysgeusia | 17 (46) | 13 (35) | 4 (11) | 0 | 0 |
| Dry mouth | 13 (35) | 13 (35) | 0 | 0 | 0 |
| Weight loss | 10 (27) | 9 (24) | 1 (3) | 0 | 0 |
| Vomiting | 9 (24) | 5 (14) | 4 (11) | 0 | 0 |
| Anorexia | 8 (22) | 7 (19) | 1 (3) | 0 | 0 |
| Decreased appetite | 8 (22) | 8 (22) | 0 | 0 | 0 |
| Blood creatinine increase | 6 (16) | 3 (8) | 3 (8) | 0 | 0 |
| Dehydration | 6 (16) | 1 (3) | 2 (5) | 1 (3) | 2 (5) |
| Anemia | 4 (11) | 1 (3) | 2 (5) | 1 (3) | 0 |
| Adverse experience . | Total†, n (%) . | All patients by grade*†, n (%) . | |||
|---|---|---|---|---|---|
| Group 1 . | Group 2 . | Group 3 . | Group 4 . | ||
| Fatigue | 27 (73) | 16 (43) | 10 (27) | 0 | 1 (3) |
| Thrombocytopenia | 20 (54) | 10 (27) | 3 (8) | 4 (11) | 3 (8) |
| Diarrhea | 18 (49) | 14 (38) | 4 (11) | 0 | 0 |
| Nausea | 18 (49) | 15 (41) | 3 (8) | 0 | 0 |
| Dysgeusia | 17 (46) | 13 (35) | 4 (11) | 0 | 0 |
| Dry mouth | 13 (35) | 13 (35) | 0 | 0 | 0 |
| Weight loss | 10 (27) | 9 (24) | 1 (3) | 0 | 0 |
| Vomiting | 9 (24) | 5 (14) | 4 (11) | 0 | 0 |
| Anorexia | 8 (22) | 7 (19) | 1 (3) | 0 | 0 |
| Decreased appetite | 8 (22) | 8 (22) | 0 | 0 | 0 |
| Blood creatinine increase | 6 (16) | 3 (8) | 3 (8) | 0 | 0 |
| Dehydration | 6 (16) | 1 (3) | 2 (5) | 1 (3) | 2 (5) |
| Anemia | 4 (11) | 1 (3) | 2 (5) | 1 (3) | 0 |